Altre lingue Hunan Er-Kang Pharmaceutical Co., Ltd

Azioni

300267

CNE100001781

Prezzo di chiusura Shenzhen S.E. Altri mercati azionari 00:00:00 10/07/2024			Variaz. 5gg	Var. 1 gen.
2,07 ^CNY	-1,43%		-5,48%	-35,51%

26/04	Hunan Er-Kang Pharmaceutical Co., Ltd riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI
24/04	Hunan Er-Kang Pharmaceutical Co., Ltd riporta i risultati degli utili per l'intero anno conclusosi il 31 dicembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Hunan Er-Kang Pharmaceutical Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	26/04
Hunan Er-Kang Pharmaceutical Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	24/04
Hunan Er-Kang Pharmaceutical Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	22/10/23
Hunan Er-Kang Pharmaceutical Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	27/08/23
Hunan Er-Kang Pharmaceutical Co., Ltd Announces 2022 Final Profit Distribution, Payable on 09 June 2023	02/06/23
Hunan Er-Kang Pharmaceutical Co., Ltd Approves 2022 Profit Distribution Plan	19/05/23
Hunan Er-Kang Pharmaceutical Co., Ltd Proposes Final Cash Dividend for the Year 2022	27/04/23
Hunan Er-Kang Pharmaceutical Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	26/04/23
Hunan Er-Kang Pharmaceutical Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2022	26/04/23
ER-KANG Pharma Earmarks $140 Million for Lithium Carbonate Factory; Shares Gain 7%	17/11/22
Hunan Er-Kang Pharmaceutical Co., Ltd Announces Executive Changes	15/11/22
Hunan Er-Kang Pharmaceutical Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022	26/10/22
Hunan Er-Kang Pharmaceutical Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2022	29/08/22
Hunan Er-Kang Pharmaceutical Co., Ltd Announces Profit Distribution Proposal for 2021	28/04/22
Hunan Er-Kang Pharmaceutical Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022	28/04/22
Hunan Er-Kang Pharmaceutical Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2021	27/04/22
Hunan Er-Kang Pharmaceutical Co., Ltd signed equity purchase agreement to acquire Henan Yuxingkang Pharmaceutical Co., Ltd. from Shuai Fangwen and Cao Zaiyun for CNY 44 million.	28/10/21
Hunan Er-Kang Pharmaceutical Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2021	27/10/21
Hunan Er-Kang Pharmaceutical Co., Ltd(XSEC:300267) added to S&P Global BMI Index	20/09/21
Hunan Er-Kang Pharmaceutical Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2021	26/08/21

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Hunan Er-Kang Pharmaceutical Co., Ltd

Azioni

300267

CNE100001781

Altre lingue

Filtri